Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioNTech ADR is a Germany-based biotechnology company focused on researching and developing innovative mRNA technologies. As a pioneer in personalized cancer immunotherapies and vaccines against infectious diseases, including its COVID-19 vaccine, BioNTech leverages its pharmaceutical expertise to drive medical advancements.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioNTech ADR is scheduled to report its next quarterly earnings on 11/03/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioNTech ADR last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -3.69 USD.
Across its last 3 earnings reports, BioNTech ADR stock moved by ±7.3% on average the following day. The largest reaction was -17.9% on 03/10/2026; 1 of 3 reactions were positive.
BioNTech ADR has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.